Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Committee approves March 2025 pharmacy and medical formulary updates, adds Stelara biosimilars
Summary
The Senate State Agencies & Governmental Affairs committee reviewed and approved March 2025 updates to the pharmacy and medical drug formularies, adding biosimilars for Stelara and reclassifying certain medications; both items were approved without objection.
The State Agencies & Governmental Affairs Senate committee reviewed and approved updates to the March 2025 pharmacy formulary and accompanying medical drug recommendations, moving several biosimilars onto the formulary and reclassifying select medications, a division director said.
Grant Wallace, director of the Employee Benefits Division, told the committee that the changes…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
